Investing Profile

David Mott

Photo of David Mott, General Partner at New Enterprise Associates (NEA)
Your Intro Paths to David Mott

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →

Find David Mott on

cb
Current Investing Position
New Enterprise Associates (NEA) General Partner
Investment Range
$200K - $40.0M
Sweet Spot
$10.0M
Investments On Record
14
Current Fund Size
$3.6B

David Mott is on these Sector & Stage Rankings

David Mott's Investments On Record (10)

CompanyStageDateRound SizeTotal Raised
Sagimet Biosciences
Series EAug 2019$7M
$113.6M
Co-investors: Robert Garland (New Enterprise Associates (NEA)), Beth Seidenberg (Westlake Village BioPartners)
Nightstar Therapeutics
Series CJun 2017$45M
Series BNov 2015$35M
$80M
Ardelyx
Post-IPO EquityJul 2016$110M
Post-IPO EquityJun 2015$77.8M
Series BAug 2011$30M
$217.8M
Clementia Pharmaceuticals
Venture RoundJun 2015$60M
$60M
Adaptimmune
Series ASep 2014$104M
$104M
Co-investors: Ali Behbahani (New Enterprise Associates (NEA))
Cydan
Venture RoundOct 2013$10M
Venture RoundApr 2013$16M
$26M
Edimer Pharmaceuticals
Series BJul 2013$18M
$18M
Prosensa
Venture RoundJan 2012€23M
€23M